A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
Clinical trial NCT07561294 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07561294
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2028-11-09
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.